Description:

NSABP PROTOCOL B-38Treatment Form for Group 3 - Doxorubicin, CyclophosphamideFollowed by Paclitaxel and Gemcitabine (DD AC - PG) - Form T3 NCT00093795 Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DD87CFFD-F7B4-2E98-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DD87CFFD-F7B4-2E98-E034-0003BA12F5E7

  1. 12/18/14 12/18/14 - Martin Dugas
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 6/16/15 6/16/15 -
Uploaded on:

June 16, 2015

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

NSABP PROTOCOL B-38Treatment Form for Group 3 - Doxorubicin, CyclophosphamideFollowed by Paclitaxel and Gemcitabine (DD AC - PG) - Form T3 NCT00093795

No Instruction available.

  1. StudyEvent: NSABP PROTOCOL B-38Treatment Form for Group 3 - Doxorubicin, CyclophosphamideFollowed by Paclitaxel and Gemcitabine (DD AC - PG) - Form T3
    1. No Instruction available.
Patient demographics
Are data amended? (check box if yes, and circle amended items)
Assessment of Chemotherapy
Agent Name
Was this cycle delayed due to adverse event(s)? (Circle Y or N for Yes, No)
Reason Treatment Ended (or Never Started Select only one)

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial